Literature DB >> 32304491

COVID-19: guidance for infection prevention and control in nuclear medicine.

John R Buscombe, Alp Notghi, Jilly Croasdale, Manish Pandit, Joseph O'Brien, Richard Graham, Stewart Redman, Sobhan Vinjamuri.   

Abstract

This guidance document is a brief consensus document covering the range and breadth of nuclear medicine practice in the UK, and identifies a few steps individual nuclear medicine practitioners and departments can take in the best interests of their patients. This guidance document should be used to inform local practice and does not replace local Trust policies or any relevant legislation. At all times, the best interests of the patients should be paramount. Please read this guidance in conjunction with previous editorial (COVID-19- Nuclear Medicine Departments, be prepared! by Huang HL, Allie R, Gnanasegaran G, Bomanji. J Nucl Med Commun 2020; 41:297-299). Although some aspects of this guidance are time-sensitive due to the nature of the global emergency, we believe that there is still sufficient information to provide some key guiding principles.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32304491     DOI: 10.1097/MNM.0000000000001206

Source DB:  PubMed          Journal:  Nucl Med Commun        ISSN: 0143-3636            Impact factor:   1.690


  10 in total

1.  Hyperthyroid radioiodine therapy in the time of COVID-19: easy does it.

Authors:  Nathan J Dickinson; Jim O'Doherty
Journal:  Nucl Med Commun       Date:  2021-04-01       Impact factor: 1.698

Review 2.  Updated clinical management guidance during the COVID-19 pandemic: thyroid nodules and cancer.

Authors:  Evanthia Giannoula; Ioannis Iakovou; Luca Giovanella; Alexis Vrachimis
Journal:  Eur J Endocrinol       Date:  2022-02-28       Impact factor: 6.664

3.  Impact of COVID-19 pandemic on 2-[18F]FDG PET/CT imaging work-flow in a single medical institution: comparison among the three Italian waves.

Authors:  Simone Maurea; Claudia Bombace; Ciro Gabriele Mainolfi; Alessandra Annunziata; Ludovica Attanasio; Arnaldo Stanzione; Elide Matano; Brigitta Mucci; Alessandro D'Ambrosio; Claudia Giordano; Mario Petretta; Silvana Del Vecchio; Alberto Cuocolo
Journal:  Heliyon       Date:  2022-01-22

4.  Impact of the COVID-19 pandemic in nuclear medicine departments: preliminary report of the first international survey.

Authors:  Salvatore Annunziata; Matteo Bauckneht; Domenico Albano; Giovanni Argiroffi; Diletta Calabrò; Elisabetta Abenavoli; Flavia Linguanti; Riccardo Laudicella
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-05-27       Impact factor: 9.236

5.  PET/CT of COVID-19 as an Organizing Pneumonia.

Authors:  Jaime Alonso Sanchez; Julia García Prieto; Alvaro Galiana Morón; John Patrick Pilkington-Woll
Journal:  Clin Nucl Med       Date:  2020-08       Impact factor: 10.782

Review 6.  Beyond the clot: perfusion imaging of the pulmonary vasculature after COVID-19.

Authors:  Ranju T Dhawan; Deepa Gopalan; Luke Howard; Angelito Vicente; Mirae Park; Kavina Manalan; Ingrid Wallner; Peter Marsden; Surendra Dave; Howard Branley; Georgina Russell; Nishanth Dharmarajah; Onn M Kon
Journal:  Lancet Respir Med       Date:  2020-11-17       Impact factor: 30.700

7.  V/Q SPECT/CT in the Time of COVID-19: Changing the Order to Improve Safety Without Sacrificing Accuracy.

Authors:  Wolfgang M Schaefer; D Knollmann; Philipp T Meyer
Journal:  J Nucl Med       Date:  2021-05-07       Impact factor: 10.057

Review 8.  Coronavirus Pandemic: What Nuclear Medicine Departments Should Know.

Authors:  Gopinath Gnanasegaran; Hian Liang Huang; Jessica Williams; Jamshed Bomanji
Journal:  J Nucl Med Technol       Date:  2020-04-20

9.  Single photon emission computed tomography lung perfusion imaging during the COVID-19 pandemic: does nuclear medicine need to reconsider its guidelines?

Authors:  Stefan Vöö; Sabina Dizdarevic
Journal:  Nucl Med Commun       Date:  2020-09       Impact factor: 1.698

10.  Low-Dose Radiation to COVID-19 Patients to Ease the Disease Course and Reduce the Need of Intensive Care.

Authors:  Poul Flemming Høilund-Carlsen; Poul-Erik Braad; Oke Gerke; Kasper Karmark Iversen; Werner Vach
Journal:  J Nucl Med       Date:  2020-07-03       Impact factor: 10.057

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.